Drs. Feudtner, Lewin, and Cohen discuss the challenges that emerge when the community of providers have different and strong opinions about the benefit of innovative surgical interventions.. Using the example of hypoplastic left heart syndrome, they explore when physicians should discuss options that they personally believe are wrong, but that other doctors think are much better.
Challenging Decision-Making in High-Risk Surgical Infants: A Tool to Help Families and Providers
Do Physicians Exert Undue Influence When Recruiting for Clinical Trials in the NICU?
Should Children with Disability Be Listed for Heart Transplant?
Sconyers/Godfrey Ethics Grand Rounds.Commentator: David Magnus, PhD, Thomas A. Raffin Professor in Medicine and Biomedical Ethics, Director, Stanford Center for Biomedical Ethics, StanfordCase...
Ethics of Early-Phase Trials in Children with Cancer
Treuman Katz Bioethics LectureSteven Joffe, MD, MPH, University of Pennsylvania Perelman School of Medicine
Find out by selecting your child’s symptom or health condition in the list below: